Buy more, pay lessMost research runs use more than one vial. Save up to 15%.
🔒 Secure checkout
Sold out
Restock in progress. Add your email and we will tell you the moment this compound is back in stock.
One email when this is back in stock. No spam, unsubscribe anytime.
🇺🇸Made in the USASynthesised domestically
📦Tracked shippingShips Mon to Fri
🔒Secure paymentReal customer support
🔄Reship policyClear terms, no hassle
About this compound
Thymosin Alpha-1 is a synthetic 28-amino-acid acetylated peptide originally isolated from thymic tissue, and a member of the thymic peptide class. It carries an acetylated N-terminus and is the same sequence whether produced by synthesis or derived from thymosin fraction five.
In the published preclinical literature, Thymosin Alpha-1 has been characterised at the cellular and molecular level for how it engages Toll-like receptor signalling on myeloid cells, with cultured and animal-model work mapping its association with dendritic-cell surface-marker expression and with intracellular kinase cascades such as the mitogen-activated protein kinase pathway. It is supplied as a research compound and is not intended for human or veterinary use.
Form
Supplied as a lyophilised powder, 10mg per vial.
Vial size
10mg per vial.
CAS
62304-98-7
Molecular formula
C129H215N33O55
Storage
Store the sealed lyophilised vial at -20°C, away from direct sunlight and protected from light.
Shelf life
The lyophilised form has a shelf life of up to 24 months when stored as directed.
Handling
Handle in accordance with standard laboratory safety practice. A Certificate of Analysis and a Safety Data Sheet are available on request.
Intended use
For research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures.
Research
Thymosin Alpha-1 has been characterised in preclinical laboratory models. The primary studies below, in cultured murine myeloid cells, examined cell-surface and intracellular-signalling endpoints, with the work centred on how the thymic peptide engages dendritic-cell maturation markers and the mitogen-activated protein kinase cascade. The literature is preclinical; it describes the compound, not any outcome in humans.
Links open the original study on PubMed. For research and educational purposes, descriptive of the published preclinical literature, not therapeutic claims about any ai-peptides product.
Independently issued per batch. Verify directly with the issuing lab.Open full size ↗
30-second check, free
Can you read a peptide COA? Take the check and find out.3 quick questions. See your COA reading result, then we send the one-page checklist and your 10% off code to your inbox.
30-second check
How well can you read a peptide COA?
3 quick questions. See where you stand, get the one-page checklist that settles it, and 10 percent off your first order.
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration, and are not intended to diagnose, treat, cure or prevent any disease.
